Business
CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing
MONMOUTH JUNCTION, N.J., Dec. 17, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its
About this update from Cytosorbents Corporation
[{"type":"text","content":"MONMOUTH JUNCTION, N.J., Dec. 17, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the world, announces the promotion of Dr. Christian Steiner to Executive Vice President - Sales and Marketing of CytoSorbents Corporation, effective immediately. Dr. Steiner will continue as Co-Managing Director of CytoSorbents Europe GmbH, and its subsidiaries.\n\n \n \n \n \n \n \n\n \nDr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents stated, \"I am pleased to have this opportunity to publicly recognize Christian's great contributions to CytoSorbents over the more than 9 years we have been working together. Christian has been instrumental in building the CytoSorb business from the very beginning, establishing an initially unknown therapy to now a market leader in our field that has generated more than $100 million in cumulative sales. He has led the growth and management of CytoSorbents Europe GmbH as Co-Managing Director, building a world-class commercialization team that has resulted in a solid multi-year history of increasing CytoSorb adoption, published data, and sales growth. Christian combines a strong science and medical understanding with more than 20 years of sales and marketing experience introducing innovative medical devices to the critical care market. As a key member of our corporate management team who has coordinated the commercialization of CytoSorb, Christian is a visionary that excels at strategy, critical thinking, problem solving, organization, and execution with more contributions to the company than can be counted. On behalf of the Board of Directors and the management team, we thank Christian for a job well-done, congratulate him on this well-deserved promotion, and look forward to even greater levels of future success.\"\nDr. Christian Steiner stated, \"At the first meeting with Phil and Vince in Berlin many years ago, I already felt that CytoSorb had the potential to save thousands, and perhaps even millions of lives one day. It is such a strikingly simple yet powerful technology that gets to the core of the deadly systemic inflammation that kills patients in the ICU. I exactly remember how we first established ou...